2022 Taiwan lipid guidelines for primary prevention
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Date Issued
2022-06-14
Author(s)
Huang, Po-Hsun
Lu, Ya-Wen
Tsai, Yi-Lin
Chang, Hsin-Yun
Wu, Chih-Hsing
Yang, Chih-Yu
Tarng, Der-Cherng
Huang, Chin-Chou
Lin, Chao-Feng
Chien, Shih-Chieh
Wu, Yih-Jer
Yeh, Hung-I
Pan, Wen-Harn
Li, Yi-Heng
Abstract
Elevated circulating low-density lipoprotein cholesterol (LDL-C) is a major risk factor of atherosclerotic cardiovascular disease (ASCVD). Early control of LDL-C to prevent ASCVD later in life is important. The Taiwan Society of Lipids and Atherosclerosis in association with the other seven societies developed this new lipid guideline focusing on subjects without clinically significant ASCVD. In this guideline for primary prevention, the recommended LDL-C target is based on risk stratification. A healthy lifestyle with recommendations for foods, dietary supplements and alcohol drinking are described. The pharmacological therapies for LDL-C reduction are recommended. The aim of this guideline is to decrease the risk of ASCVD through adequate control of dyslipidemia in Taiwan.
Subjects
Atherosclerosis; Cholesterol; Taiwan
SDGs